This page shows the latest The Lancet news and features for those working in and with pharma, biotech and healthcare.
weeks. This recommendation was based on a study that showed that extending the time between doses improves the efficacy of the vaccine. ... The data, published in a preprint with The Lancet, reported that ‘vaccine efficacy was higher, after the second
Late-stage trial results published in The Lancet found that the vaccine was 91.6% effective at protecting against COVID-19. ... We welcome the start of the rolling review procedure by EMA of Sputnik V.
The study, which launched last Friday, will begin the first vaccinations in February. ... New data, published in a preprint with The Lancet, reported that the efficacy of the ChAdOx1 nCoV-19 vaccine was higher after the second dose in those with a dosing
German media reports suggested vaccine is less than 10% effective in the elderly. ... In response, AZ said that the reports were “completely incorrect”, further highlighting data published in The Lancet last November.
of the AZ/Oxford vaccine followed by the Russian vaccine on day 29 of the study. ... Last month, The Lancet published peer-reviewed results from an interim analysis of AZ/Oxford’s phase 3 COVID-19 vaccine programme, confirming the vaccine to be 70.4%
SNG001 delivers an inhaled formulation of Interferon-beta-1a directly to the lungs. ... The findings, published in The Lancet, also found that over the 14-day treatment period, patients in the SNG001 group were more than twice as likely to recover
More from news
Approximately 2 fully matching, plus 136 partially matching documents found.
In the context of a global pandemic, this timeline was reduced to months. ... They were coordinated by the China-Japan Friendship Hospital in Beijing. The results from the severe study was published in The Lancet.
We’re not ready’. Gates said: “Today, the greatest risk of global catastrophe. ... According to a paper in The Lancet, early research has found that nearly 15% of all COVID-19 patients acquire deadly secondary bacterial infections.
Will COVID-19 help or hinder the quest to increase uptake of other vaccinations? ... Recent controversies surrounding the release of data on promising COVID-19 therapies in press releases prior to publication of detailed trial results, and the retraction
In 2017, two serving Dutch ministers wrote in The Lancet that ‘the system is broken… companies can ask the price they like’. ... If the OMP Regulation is reopened, we may see a new law proposed by 2021.
Pharma joins in the congratulations – but conflicts will continue. Richard Horton, the editor of The Lancet, insists in a Guardian article that the NHS should no longer be viewed as a ... lead to poor health such as poverty, and upgrading the quality
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
Boulding joins with more than 25 years of experience in the pharma industry, having worked in sales and marketing prior to moving into senior client roles in healthcare advertising agencies. . ... Pound, too, has significant medical communications and
His experience prior to Pollen includes the role of managing director for Cohn &Wolfe's healthcare business and senior business director at Ogilvy Healthworld. ... He also has experience at publishing firms The Lancet and Medpress.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Observable effects of climate change are already being felt – for example, the Lancet’s 2019 report on the infection rates of dengue fever (expressed as vectorial capacity for transmissions) showed that ... In 2015 the global pharmaceutical industry
Trust in vaccines fell as a result of emotional contagion, triggered by the 1998 publication of Andrew Wakefield's paper in the Lancet linking the MMR vaccine with autism and bowel ... But the majority of the public don't even read the mainstream media.
16. Snoek, F.J., Bremmer, M.A. and Hermanns, N., 2015. Constructs of depression and distress in diabetes: time for an appraisal. The Lancet Diabetes &Endocrinology, 3(6), pp.450-460. ... 22. Diabetes UK (2017) The Future of Diabetes
opening of a recent editorial in the Lancet on multiple myeloma. ... This meant significant cost in terms of toxicity, and marginal impact on the overall survival of patients. .
Public sector healthcare reforms. Turkey’s implementation of universal healthcare coverage has received considerable global acclaim. Notably in 2013, an article was published in the Lancet hailing the success of the ... The government has actively
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...